Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Breast and Non-Small Cell Lung Cancer (NSCLC)
07:30am - 03:45pm EDT - March 31, 2023
07:30am - 03:45pm EDT - March 31, 2023
Author(s):
- Mr. Mason Alford, MSc, Medical Student, Vanderbilt School of Medicine
Tags: Member Institution Clinical Oncology
| Display Label | Action |
|---|---|
| Alford NCCN Poster.pdf | Download Handout |
| AC23P17 - Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Breast and Non-Small Cell Lung Cancer (NSCLC) | Download MP3 |
